Seizures and Epilepsy in The Acute Medical Setting: Presentation and Management
Seizures and Epilepsy in The Acute Medical Setting: Presentation and Management
Seizures and Epilepsy in The Acute Medical Setting: Presentation and Management
Epileptic seizures are a common cause for presentation may be associated with a high mortality rate, likely reflecting a
high-risk subgroup of patients5 and not uncommonly presents with
ABSTRACT
Table 1. The Sheldon questionnaire. The patient has Box 1. Indications for urgent brain imaging and/or
seizures if point score ≥1, and syncope if score is <1. hospital admission
The same questions can be asked of a witness Indications for urgent brain imaginga and/or hospital
Questions shown to distinguish seizures from Points admission
syncope (if yes) Acute head trauma
New onset focal neurologic deficit
At times do you wake with a cut tongue after your spells? 2 Altered mental status persists (behaviour or cognition)
At times do you have a sense of déjà vu or jamais vu 1 Recurrent events
before your spells?
Persistent headache
At times is emotional stress associated with losing 1
Anticoagulation
consciousness?
A history of immunodeficiency or malignancy
Has anyone noted your head turning during a spell? 1
Fever
Has anyone ever noted that you are unresponsive, 1
have unusual posturing or have jerking limbs Focal seizure (partial seizure)
during your spells or have no memory of your spells New neurological symptoms prior to the seizure
afterwards? (Score as yes for any positive response)
Patients in whom follow-up cannot be ensured
Has anyone ever noted that you are confused after a spell? 1 a
Urgent imaging is not required for syncope, non-epileptic seizures, or patients
Have you ever had lightheaded spells? −2 with well-characterised epilepsy or recurrent admissions with drug/alcohol-
provoked seizures in the absence of any additional reason to suspect new
At times do you sweat before your spells? −2 intracranial pathology
Is prolonged sitting or standing associated with your spells? −2
Reproduced with permission.7
Acute symptomatic seizures
This encompasses all seizures that occur in close association with a
Antiepileptic medication is not indicated for a single seizure,
brain insult. The International League Against Epilepsy (ILAE) has
unless investigations indicate a high risk of seizure recurrence.12
proposed specific parameters where seizures can be called acute
Other than in status epilepticus, starting antiepileptic drugs
symptomatic (see Table 2).14 In these circumstances treatment
should ideally be a specialist decision. In the interim, the patient
should not be initiated unless there are multiple seizures, or if the
should be given basic safety and driving advice.
patient is in status epilepticus, followed by prompt specialist input
> Driving: by law patients must refrain from driving until specialist with respect to continuation. The risk of seizure recurrence is often
assessment. If a seizure is confirmed, the Driver and Vehicle minimal so long-term treatment with antiepileptic drugs is not
Licensing Agency (DVLA) must be informed and a group 1 required.
licence will usually be revoked for a minimum of 6 to 12 months
(depending on the presence/absence of abnormalities on Seizures in known epilepsy
magnetic resonance imaging [MRI] / electroencephalogram
[EEG]). This is an extremely common scenario. Patients can present
> Safety and lifestyle: shower rather than bath; avoid heights / reporting deterioration in their usual frequency for a range of
dangerous equipment; occupational/parenting guidance; first reasons including:
aid in the event of recurrent events; and who to contact. > patient/family anxiety about perceived changes
> intercurrent infections / systemic illnesses
Investigations: who should have urgent brain > alcohol and recreational drug use
imaging and who should be admitted? > medication related: eg poor adherence, changes in formulation/
brand, during planned withdrawal / changes to medication,
All patients with a first seizure presentation should be
drug interactions with other prescribed and over the counter
investigated with routine blood tests to exclude infection or
medications
metabolic disturbance and should have an electrocardiogram
> new acute symptomatic seizures, for example due to a head injury.
(ECG). The majority of uncomplicated first seizure patients do
not require urgent brain imaging before discharge. MRI is the The history is key. Is the seizure pattern unusual for the
imaging modality of choice to investigate seizures and will patient? Ask how often seizures occur at their worst or their best.
be organised via a first seizure clinic. Urgent brain imaging Confusion about the patient’s normal seizure pattern can occur
(preferably with MRI, but with computed tomography [CT] if MRI in new environments, for example, a stranger may have called an
is not available / feasible acutely) before discharge should be ambulance unnecessarily. If the above precipitants have been
considered in those patients where an acute intracranial event is excluded, fluctuations in seizure frequency may occur simply due
suspected (see Box 1). to the natural variability of epilepsy.
Patients with abnormal imaging, prolonged or recurrent events, If adherence has been poor, try to establish why, in order to
or incomplete recovery may justify a brief admission for more address the root cause (eg side effects needing a change in drug/
urgent (inpatient) medical and neurological assessment.13 dose, forgetfulness – would a blister pack help?)
Stabilise paent
Secure airway (recovery posion) and give oxygen
Call for help
Monitor vital signs and instute cardiac monitoring
Immediate measures Establish IV access and take venous blood samples for glucose, LFT, U+E, Mg2+, CA2+,
FBC, toxicology screening and anepilepc drug levels
If there are concerns about hypoglycaemia, poor nutrion or alcohol excess, give 250
mg of thiamine IV, followed by 50 mL of 50% glucose IV over 10 minutes (consider
1 mg IM glucagon if IV access not available)
16 Ferguson M, Bianchi MT, Sutter R et al. Calculating the risk benefit 20 Fisher RS, Cross JH, French JA et al. Operational classification of
equation for aggressive treatment of non-convulsive status epilep- seizure types by the International League Against Epilepsy: position
ticus. Neurocrit Care 2013;18:216–27. paper of the ILAE Commission for Classification and Terminology.
17 Yasiry Z, Shorvon SD. The relative effectiveness of five antiepi- Epilepsia 2017;58:522–30.
leptic drugs in treatment of benzodiazepine-resistant convulsive
status epilepticus: a meta-analysis of published studies. Seizure
2014;23:167–74.
18 Bleck T, Cock H, Chamberlain J et al. The Established Status
Epilepticus Trial 2013. Epilepsia 2013;54:89–92.
19 Glauser T, Shinnar S, Gloss D et al. Evidence-based guideline: treat- Address for correspondence: Dr Howard John Faulkner,
ment of convulsive status epilepticus in children and adults: report Department of Neurology, Brunel Building, Southmead
of the guideline committee of the American Epilepsy Society. Hospital, Bristol BS10 5NB, UK.
Epilepsy Curr 2016;16:48–61. Email: [email protected]